The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.

Delia BogdanetMichelle Toth CastilloHelen DohenyLouise DervanMiguel Angel Luque-FernandezJose A HalperinPaula M O'SheaFidelma P Dunne

Published in: Acta diabetologica (2022)

This study has shown that pGCD59 has the potential to predict adverse pregnancy outcomes. Prospective studies with a larger number of cases are necessary to fully explore and validate the potential of this emerging biomarker in predicting adverse pregnancy outcomes.

Keyphrases

pregnancy outcomes
pregnant women
type diabetes
adverse drug
human health